Cataract Clinical Trial
Official title:
Comparison of the Capsular Stability With Two Different IOL Models in Patients With Pseudoexfoliation Syndrome: an Exploratory Study
The pseudoexfoliation (PXF syndrome) is caused by production and deposition of extracellular
material in the anterior chamber of the eye as well as in other tissues of the body. Approx.
70 million worldwide have a PXF syndrome.
After cataract surgery a decentration and subluxation of the intraocular lens (IOL) happens
more frequently than in the general population due to a higher incidence of zonular weakness
and an increased capsular fibrotic reaction.
Decentration, tilt and / or rotation of the lens can reduce the quality of vision.
It is believed that the design of the implanted IOL, more precisely the front surface of the
IOL has an influence on the extent of capsular fibrosis and contraction. Especially in
presence of capsular instability, as it is in patients with Pseudoexfoliation syndrome the
design of the IOL has an effect on the post-operative stability.
In this study, two different IOL models are compared in terms of their stability. The
"Tecnis 1-piece ZCB00" (AMO, USA), with a concave lowering comprising the lens edge and the
"Acrysof SA60AT" (Alcon, USA), with a biconvex design are compared. Forty eyes of 20
patients are planned to be included in this study. One eye receives the "Tecnis ZCB00
1-piece "(AMO, USA), while the other eye receives the"Acrysof SA60AT "(Alcon, USA).
In which eye which IOL is implanted, is assigned by randomization. To measure the
decentration, tilt and rotation of the IOL an examination will be performed before the
operation and there will be follow-ups one hour after the operation of the first eye, one
hour after the operation of the second eye, three months and twelve months after the
operation on the second eye. All measurements will be done without touching the eye.
Status | Recruiting |
Enrollment | 30 |
Est. completion date | February 2015 |
Est. primary completion date | February 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 21 Years and older |
Eligibility |
Inclusion Criteria: - Age-related cataract - Age 21 and older - Pseudoexfoliation syndrome - written informed consent prior to surgery Exclusion Criteria: - Relevant ophthalmic diseases that could affect corneal transparency or the ability for fixation of LEDs - In case of pregnancy (pregnancy test will be taken preoperatively in women of reproductive age) |
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Austria | VIROS - Vienna Institute for Research in Ocular Surgers - Departement of Opthalmology - Hanusch Hospital | Vienna |
Lead Sponsor | Collaborator |
---|---|
Vienna Institute for Research in Ocular Surgery |
Austria,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference between the two IOLS in postoperative IOL tilt (degrees) and decentration (mm) measured with the Purkinjemeter | 12 months | No | |
Secondary | Horizontal and vertical IOL tilt (in °) evaluated from AS-OCT and Scheimpflug images | 12 months | No | |
Secondary | Change in rhexis diameter (mm in retroillumination foto) | 12 months | No | |
Secondary | Change in anterior chamber depth (in mm) measured with the AC Master | 12 months | No | |
Secondary | Subjective evaluation of IOL - anterior capsule interconnection ( capsule overlapping the IOL optic edge in slitlamp examination) | 12 months | No | |
Secondary | Change in aqueous flare measured with laser flare meter | 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |